Contrast detection, discrimination and adaptation in patients with Parkinson's disease and multiple system atrophy

Brain

Volumn 120, Issue 12, 1997, Pages 2219-2228

  Tebartz Van Elst, L ^a   Greenlee, M W ^a   Foley, J M ^b   Lucking C H ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Adaptation; Contrast discrimination; Multiple system atrophy; Neurodegenerative diseases; Parkinson's disease

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTRAST SENSITIVITY; CONTROLLED STUDY; GRATING; HUMAN; HYPOTHESIS; PARKINSON DISEASE; PRIORITY JOURNAL; RESPONSE TIME; RETINA; SHY DRAGER SYNDROME; VISUAL ADAPTATION; VISUAL DISCRIMINATION; VISUAL STIMULATION; VISUAL THRESHOLD;

EID: 0031436043     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/120.12.2219     Document Type: Article

References (76)

1. Albrecht DG, Hamilton DB. Striate cortex of monkey and cat: contrast response function. J Neurophysiol 1982; 48: 217-37.
2. Allison JD, Casagrande VA, Debruyn EJ, Bonds AB. Contrast adaptation in striate cortical neurons of the nocturnal primate bush baby (Galago crassicaudatus). Vis Neurosci 1993; 10: 1129-39.
3. Bartel P, Blom M, Robinson E, Van der Meyden C, Sommers DK, Becker P. Effects of chlorpromazine on pattern and flash ERGs and VEPs compared to oxazepam and to placebo in normal subjects. Electroencephalogr Clin Neurophysiol 1990; 77: 330-9.
4. Blakemore C, Campbell FW. On the existence of neurones in the human visual system selectively sensitive to the orientation and size of retinal images. J Physiol (London) 1969; 203: 237-60.
5. Blakemore C, Muncey JP, Ridley RM. Stimulus specificity in the human visual system. Vision Res 1973; 13: 1915-31.
6. Bloxham C, Dick DJ, Moore M. Reaction times and attention in Parkinson's disease. J Neurol Neurosurg Psychiatry 1987; 50: 1178-83.
7. Bodis-Wollner I. Visual deficits related to dopamine deficiency in experimental animals and Parkinson's disease patients. [Review]. Trends Neurosci 1990; 13: 296-302.
8. Bodis-Wollner I, Yahr MD. Measurements of visual evoked potentials in Parkinson's disease. Brain 1978; 101: 661-71.
9. Bodis-Wollner I, Marx MS, Mitra S, Bobak P,Mylin L, Yahr M. Visual dysfunction in Parkinson's disease. Loss in spatiotemporal contrast sensitivity. Brain 1987; 110: 1675-98.
10. Breitmeyer BG. Simple reaction time as a measure of the temporal response properties of transient and sustained channels. Vision Res 1975; 15: 1411-2.
11. Brown RG. Marsden CD. Dual task performance and processing resources in normal subjects and patients with Parkinson's disease. Brain 1991; 114: 215-31.
12. Bulens C, Meerwaldt JD, Van der Wildt GJ. Effect of stimulus orientation on contrast sensitivity in Parkinson's disease. Neurology 1988; 38: 76-81.
13. Bulens C, Meerwaldt JD, Van der Wildt GJ, Van Deursen JB. Effect of levodopa treatment on contrast sensitivity in Parkinson's disease. Ann Neurol 1987; 22: 365-9.
14. Bulens C, Meerwaldt JD, Van der Wildt GJ, Keemink CJ. Visual contrast sensitivity in drug-induced parkinsonism. J Neural Neurosurg Psychiatry 1989; 52: 341-5.
15. Crawford T, Goodrich S, Henderson L, Kennard C. Predictive responses in Parkinson's disease: manual keypresses and saccadic eye movements to regular stimulus events. J Neurol Neurosurg Psychiatry 1989; 52: 1033-42.
16. Dean AF. Adaptation-induced alteration of the relation between response amplitude and contrast in cat striate cortical neurones. Vision Res 1983; 23: 249-56.
17. DeBruyn EJ, Bonds AB. Contrast adaptation in cat visual cortex is not mediated by GABA. Brain Res 1986; 383: 339-42.
18. Delalande L, Destee A, Hache JC, Forzy G, Bughin M, Benhadjali J. Visual evoked potentials and spatiotemporal contrast sensitivity changes in idiopathic Parkinson's disease and multiple system atrophy. Adv Neurol 1996; 69: 319-25.
19. Delwaide PJ, Mesraoua B, De Pasqua, V. Les potentiels evoques visuels dans la maladie de Parkinson. Rev Electroencephalogr Neurophysiol Clin 1980; 10: 338-42.
20. Domenici L, Trimarchi C, Piccolino M, Fiorentini A, Maffei L. Dopaminergic drugs improve human visual contrast sensitivity. Hum Neurobiol 1985; 4: 195-7.
21. Dowling JE, Ehinger B. Synaptic organization of the aminecontaining interplexiform cells of the goldfish and Cebus monkey retinas. Science 1975; 188: 270-3.
22. Ejima Y, Ohtani Y. Analysis of simple reaction time to a sinusoidal grating by means of a linear filter model of the detection process. Percept Psychophys 1989; 46: 119-26.
23. Foley JM, Boynton GM. Forward pattern masking and adaptation: effects of duration, interstimulus interval, contrast, and spatial and temporal frequency. Vision Res 1993; 33: 959-80.
24. Foley JM, Legge GE. Contrast detection and near-threshold discrimination in human vision. Vision Res 1981; 21: 1041-53.
25. Foster DH, Bischof WF. Thresholds from psychometric functions: superiority of bootstrap to incremental and probit variance estimators. Psychol Bull 1991; 109: 152-9.
26. Frederick JM, Rayborn ME, Laties AM, Lam DMK, Hollyfield JG. Dopaminergic neurons in the human retina. J Comp Neurol 1982; 210: 65-79.
27. Gawel MJ, Das P, Vincent S. Rose FC. Visual and auditory evoked responses in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 1981; 44: 227-32.
28. Georgeson MA. The effect of spatial adaptation on perceived contrast. Spat Vis 1985; 1: 103-12.
29. Ghilardi MF, Marx MS. Bodis-Wollner I, Camras CB, Glover AA. The effect of intraocular 6-hydroxydopamine on retinal processing of primates. Ann Neurol 1989; 25: 357-64.
30. Gibb WR. Lees AJ. Anatomy, pigmentation, ventral and dorsal subpopulations of the substantia nigra, and differential cell death in Parkinson's disease. J Neurol Neurosurg Psychiatry 1991; 54: 388-96.
31. Graham JG, Oppenheimer DR. Orthostatic hypertension and nicotine sensitivity in a case of multiple system atrophy. J Neurol Neurosurg Psychiatry 1969; 32: 28-34.
32. Gray F. Neuropathologie des syndromes parkinsoniens. Rev Neurol (Paris) 1988; 144: 229-48.
33. Greenlee MW, Breitmeyer BG. A choice reaction time analysis of spatial frequency discrimination. Vision Res 1989; 29: 1575-86.
34. Greenlee MW, Heitger F. The functional role of contrast adaptation. Vision Res 1988; 28: 791-7.
35. Greenlee MW, Georgeson MA, Magnussen S, Harris JP. The time course of adaptation to spatial contrast. Vision Res 1991 ; 31: 223-36.
36. Haggendal J, Malmfors T. Evidence of dopamine-containing neurons in the retina of rabbits. Acta Physiol Scand 1963; 59: 295-6.
37. Harnois C, Di Paolo T. Decreased dopamine in the retinas of patients with Parkinson's disease. Invest Ophthalmol Vis Sci 1990; 31: 2473-5.
38. Harris JP, Calvert JE, Phillipson OT. Processing of spatial contrast in peripheral vision in Parkinson's disease. Brain 1992; 115: 1447-57.
39. Harwerth RS, Levi DM. Reaction time as a measure of suprathreshold grating detection. Vision Res 1978; 18: 1579-86.
40. Hendry SHC, Fuchs J, de Blas AL, Jones EG. Distribution and plasticity of immunocytochemically localized GABAa receptors in adult monkey visual cortex. J Neurosci 1990; 10: 2438-50.
41. Hoehn MM, Yahr MD. Parkinsonism. Onset, progression and mortality. Neurology 1967; 17: 427-42.
42. Hubel DH, Wiesel TN. Receptive fields, binocular interaction and functional architecture in the cat's visual cortex. J Physiol (Lond) 1962; 160: 106-54.
43. Hubel DH, Wiesel TN. Receptive fields and functional architecture of monkey striate cortex. J Physiol (Lond) 1968; 195: 215-43.
44. Ikeda H, Head GM, Ellis CJ. Electrophysiological signs of retinal dopamine deficiency in recently diagnosed Parkinson's disease. Vision Res 1994; 34: 2629-38.
45. Langheinrich T, Tebartz van Elst L, Lagreze W, Bach M, Lucking CH, Greenlee MW. Contrast response functions in Parkinson's disease (PD) measured by PERG, VEP and psychophysics [abstract]. Invest Ophthalmol Visual Sci: ARVO Suppl 1997; 38: S633.
46. Lieberman H, Pentland AP. Microcomputer-based estimation of psychophysical thresholds: the best PEST. Behav Res Meth Instru Computers 1982; 14: 21-5.
47. Maffei L, Fiorentini A, Bisti S, Holländer H. Pattern ERG in the monkey after section of the optic nerve. Exp Brain Res 1985; 59: 423-5.
48. Magnussen S, Greenlee MW. Marathon adaptation to spatial contrast: saturation in sight. Vision Res 1985; 25: 1409-11.
49. Mariani AP, Kolb H, Nelson R. Dopamine-containing amacrine cells of Rhesus monkey retina parallel rods in spatial distribution. Brain Res 1984; 322: 1-7.
50. Marx M, Bodis-Wollner I, Bobak P, Harnois C, Mylin L, Yahr M. Temporal frequency-dependent VEP changes in Parkinson's disease. Vision Res 1986; 26: 185-93.
51. Massey SC, Redburn DA. Transmitter circuits in the vertebrate retina. [Review]. Prog Neurobiol 1987; 28: 55-96.
52. Masson G, Mestre D, Blin O. Dopaminergic modulation of visual sensitivity in man. [Review], Fundam Clin Pharmacol 1993; 7: 449-63.
53. McCormick DA. GABA as an inhibitory neurotransmitter in human cerebral cortex. J Neurophysiol 1989; 62: 1018-27.
54. Mestre D, Blin O, Serratrice G, Pailhous J. Human spatio-temporal contrast sensitivity: dopaminergic induced variations. Eur J Pharmacol 1990a; 183: 1022-3.
55. Mestre D, Blin O, Serratrice G, Pailhous J. Spatiotemporal contrast sensitivity differs in normal aging and Parkinson's disease. Neurology 1990b; 40; 1710-4.
56. Montgomery EB Jr, Nuessen J. The movement speed/accuracy operator in Parkinson's disease. Neurology 1990; 40: 269-72.
57. Nguyen-Legros J, Botteri C, Le Hoang P, Vigny A, Gay M. Morphology of primate's dopaminergic amacrine cells as revealed by TH-like immunoreactivity on retinal flat-mounts. Brain Res 1984; 295; 145-53.
58. Oertel W. Multisystematrophie. In: Bastian C, Ceballos-Baumann AO, editors. Bewegungsstörungen in der Neurologie. Stuttgart: Georg Thieme Verlag, 1996: 69-77.
59. Ohzawa I, Sclar G, Freeman RD. Contrast gain control in the cat's visual system. J Neurophysiol 1985; 54: 651-67.
60. Oppenheimer D. Neuropathology of progressive autonomie failure. In: Bannister R, editor. Autonomie failure: a textbook of clinical disorders of the autonomie nervous system. Oxford: Oxford University Press, 1983: 267-83.
61. Papadopoulos GC, Parnavelas JG. Distribution and synaptic organization of dopaminergic axons in the lateral geniculate nucleus of the rat. J Comp Neurol 1990; 294: 356-61.
62. Parkinson D. Evidence for a dopaminergic innervation of cat primary visual cortex. Neuroscience 1989; 30: 171-9.
63. Playford ED, Brooks DJ. In vivo and in vitro studies of the dopaminergic system in movement disorders. [Review]. Cerebrovasc Brain Meuib Rev 1992; 4: 144-71.
64. Pullman SL, Watts RL, Juncos JL, Chase TN, Sanes JN. Dopaminergic effects on simple and choice reaction time performance in Parkinson's disease. Neurology 1988; 38: 249-54.
65. Quinn N. Multiple system atrophy -the nature of the beast. [Review]. J Neurol Neurosurg Psychiatry 1989; 52 Suppl: 78-89.
66. Quinn N. Multiple system atrophy. In: Marsden CD, Fahn S, editors. Movement disorders 3. Oxford: Butterworth-Heinemann, 1994: 262-81.
67. Reader TA, Quesney LF. Dopamine in the visual cortex of the cat. Experientia 1986; 42: 1242-4.
68. Regan D, Maxner C. Orientation-selective visual loss in patients with Parkinson's disease. Brain 1987; 110: 415-32.
69. Ross J, Speed HD. Contrast adaptation and contrast masking in human vision. Proc R Soc Lond B Biol Sci 1991; 246: 61-9.
70. Sclar G, Lennie P, DePriest DD. Contrast adaptation in the striate cortex of macaque. Vision Res 1989; 29: 747-55.
71. Skrandies W, Wässle H. Dopamine and serotonin in cat retina: electroretinography and histology. Exp Brain Res 1988; 71: 231-40.
72. Snowden RJ, Hammett ST. Subtractive and divisive adaptation in the human visual system. Nature 1992; 355: 248-50.
73. Tagliati M, Bodis-Wollner I, Yahr MD. The pattern electroretinogram in Parkinson's disease reveals lack of retinal spatial tuning. Electroencephalogr Clin Neurophysiol 1996; 100: 1-11.
74. Troscianko T, Calvert J. Impaired parallel visual search mechansims in Parkinson's disease: implications for the role of dopamine in visual attention. Clin Visual Sci 1993; 8: 281-7.
75. Weinstein A, Troscianko T, Calvert J. Impaired visual search mechansims in Parkinson's disease (PD): a psychophysical and event-related potentials study. J Psychophysiol 1997; 11: 33-47.
76. Wenning GK, Ben Shlomo Y, Magalhaes M, Daniel SE, Quinn NP. Clinical features and natural history of multiple system atrophy. Brain 1994; 117: 835-45.